Total Payments
$542,137
2024 Payments
$67,492
Companies
12
Transactions
484
Medicare Patients
676
Medicare Billing
$162,862
Payment Breakdown by Category
Other$454,336 (83.8%)
Travel$62,945 (11.6%)
Consulting$13,063 (2.4%)
Food & Beverage$11,750 (2.2%)
Education$43.72 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $454,336 | 108 | 83.8% |
| Travel and Lodging | $62,945 | 219 | 11.6% |
| Consulting Fee | $13,063 | 8 | 2.4% |
| Food and Beverage | $11,750 | 147 | 2.2% |
| Education | $43.72 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $174,663 | 139 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $136,416 | 114 | $0 (2024) |
| Daiichi Sankyo Inc. | $109,188 | 114 | $0 (2024) |
| Gilead Sciences, Inc. | $65,893 | 47 | $0 (2024) |
| PFIZER INC. | $47,085 | 61 | $0 (2022) |
| Immunomedics, Inc. | $4,525 | 3 | $0 (2020) |
| Genentech, Inc. | $3,960 | 1 | $0 (2019) |
| Allergan, Inc. | $148.15 | 1 | $0 (2022) |
| Abbott Laboratories | $103.58 | 1 | $0 (2021) |
| COMSORT, Inc | $100.00 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67,492 | 66 | Daiichi Sankyo Inc. ($36,284) |
| 2023 | $135,953 | 114 | AstraZeneca Pharmaceuticals LP ($95,417) |
| 2022 | $135,974 | 119 | Daiichi Sankyo Inc. ($43,281) |
| 2021 | $26,559 | 29 | Genentech USA, Inc. ($20,507) |
| 2020 | $5,731 | 6 | Immunomedics, Inc. ($4,525) |
| 2019 | $62,754 | 57 | Genentech USA, Inc. ($56,843) |
| 2018 | $34,172 | 39 | Genentech USA, Inc. ($17,503) |
| 2017 | $73,500 | 54 | Genentech USA, Inc. ($51,481) |
All Payment Transactions
484 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Travel and Lodging | In-kind items and services | $638.35 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Travel and Lodging | In-kind items and services | $173.21 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $73.36 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,975.00 | General |
| Category: ONC | ||||||
| 11/20/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Travel and Lodging | In-kind items and services | $54.84 | General |
| Category: ONC | ||||||
| 11/15/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,950.00 | General |
| Category: ONC | ||||||
| 11/13/2024 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $137.63 | General |
| Category: ONC | ||||||
| 10/28/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,560.00 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,920.00 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Travel and Lodging | In-kind items and services | $68.34 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Travel and Lodging | In-kind items and services | $10.00 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Travel and Lodging | In-kind items and services | $7.00 | General |
| Category: ONCOLOGY | ||||||
| 10/28/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Travel and Lodging | In-kind items and services | $7.00 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $64.34 | General |
| Category: ONCOLOGY | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,560.00 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Travel and Lodging | In-kind items and services | $114.50 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Travel and Lodging | In-kind items and services | $83.96 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Travel and Lodging | In-kind items and services | $65.00 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Travel and Lodging | In-kind items and services | $10.00 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Travel and Lodging | In-kind items and services | $432.89 | General |
| Category: Oncology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Travel and Lodging | In-kind items and services | $279.23 | General |
| Category: Oncology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Travel and Lodging | In-kind items and services | $275.20 | General |
| Category: Oncology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $76.09 | General |
| Category: Oncology | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 210 | 485 | $390,817 | $59,004 |
| 2022 | 2 | 160 | 339 | $271,407 | $40,166 |
| 2021 | 2 | 179 | 320 | $262,336 | $39,046 |
| 2020 | 2 | 127 | 245 | $199,369 | $24,646 |
Total Patients
676
Total Services
1,389
Medicare Billing
$162,862
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 159 | 434 | $335,482 | $50,808 | 15.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 51 | 51 | $55,335 | $8,196 | 14.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 130 | 309 | $238,857 | $35,435 | 14.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 30 | 30 | $32,550 | $4,731 | 14.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 131 | 272 | $210,256 | $31,550 | 15.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 48 | 48 | $52,080 | $7,496 | 14.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 95 | 213 | $164,649 | $19,904 | 12.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 32 | 32 | $34,720 | $4,742 | 13.7% |
About Dr. John Park, MD
Dr. John Park, MD is a Medical Oncology healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053375444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Park, MD has received a total of $542,137 in payments from pharmaceutical and medical device companies, with $67,492 received in 2024. These payments were reported across 484 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($454,336).
As a Medicare-enrolled provider, Park has provided services to 676 Medicare beneficiaries, totaling 1,389 services with total Medicare billing of $162,862. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Location San Francisco, CA
- Active Since 04/13/2006
- Last Updated 07/09/2007
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1053375444
Products in Payments
- ENHERTU (Biological) $131,296
- Perjeta (Biological) $74,077
- Trodelvy (Drug) $70,406
- Enhertu (Drug) $65,907
- Kadcyla (Biological) $53,743
- IBRANCE (Drug) $47,085
- ENHERTU (Drug) $43,281
- Herceptin (Biological) $30,318
- Phesgo (Biological) $20,485
- NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) $148.15
- Octrode SCS Leads (Device) $103.58
- KEYTRUDA (Biological) $100.00
- Xeomin (Biological) $36.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in San Francisco
Dr. Stephen Sherwin, M.d, M.D
Medical Oncology — Payments: $7.8M
Medical Oncology $7.8M
Kevin Kim, M.d, M.D
Medical Oncology — Payments: $200,997
Medical Oncology $200,997
Aman Chauhan, Md, MD
Medical Oncology — Payments: $73,775
Medical Oncology $73,775
Dr. Trever Bivona, M.d., Ph.d, M.D., PH.D
Medical Oncology — Payments: $54,545
Medical Oncology $54,545
Dr. Ana Velazquez Manana, Md Msc, MD MSC
Medical Oncology — Payments: $41,679
Medical Oncology $41,679
Dr. Weiyun Ai, Md, MD
Medical Oncology — Payments: $40,393
Medical Oncology $40,393